Xellar Biosystems News and Activities

Acquisition, funding and merger involving Xellar Biosystems.

• Xellar Biosystems has just announced a $50 Million fundraising (posted on June 30 2026).

View the org chart displaying its 9 main executives

Most searched biographies at Xellar Biosystems

• Xin Xie, Chief Executive Officer
• Jihye Seo, Director
• Sen Ye, Senior Director, Head of Scientific Affair and Innovation

Create your alert
to follow the executive moves at Xellar Biosystems.

Xellar Biosystems has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Xellar Biosystems

Social media about Xellar Biosystems

• Xellar Biosystems on Wikipedia, Google News & Yahoo Finance
• Xellar Biosystems on LinkedIn, X (Twitter) & YouTube